Risk of serious conditions reduced regardless of amount of weight lost, say researchers who compare breakthrough to discovery ...
Those taking the drugs for at least three years cut their risk of heart attack, stroke or cardiac death by 20 per cent ...
The weight loss jab has become a blockbuster pharmaceutical hit, with people, including the diabetics it was originally ...
A study has found the anti-obesity drug sold under brand names Wegovy, Ozempic and Rybelsus could reduce the risk of heart attacks, strokes ...
Novo Nordisk’s weight loss injection semaglutide — the ingredient inside its wildly popular drugs Ozempic and Wegovy — could ...
Anti-obesity jabs could reduce the risk of heart attacks, strokes or heart failure in obese people regardless of the amount ...
New analyses of a large trial presented at the European Congress on Obesity showed the clear benefits of the popular weight-loss drug.
Semaglutide, known by its brand name Wegovy, has become a popular weight loss tool. Here’s how it works, and the risks to ...
Study adds to evidence that semaglutide, also known by the brand names Ozempic or Wegovy, can be used for a range of chronic conditions ...
WOMEN taking ‘skinny jabs’ have been urged to pair them with effective contraception. It follows claims that the weight loss ...
Global obesity rates have nearly tripled since 1975, per WHO and Goldman Sachs. The growing usage of GLP-1 drugs in weight ...